Fortacin set for centralised OTC switch in Europe

24 July 2020 - Deborah Wilkes

Archived

Recordati’s Fortacin (lidocaine and prilocaine) is set to become the fifth medicine to gain non-prescription status through the European Union’s centralised authorisation procedure.

Click tags below for more information on topics:

Recordati

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: